Skip to main content
HR 4747 108th Congress House Agriculture and Food Administrative procedure Appropriations Authorization Business records Commerce Congress Congressional reporting requirements Consumer education Consumer protection Deceptive advertising Defective products Department of Health and Human Services Dietary supplements Drug interactions Economics and Public Finance Electronic government information Federal aid to research Federal employees Food and Drug Administration (FDA)

Dietary Supplement Regulatory Implementation Act of 2004

Introduced: June 25, 2004 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 7, 2004
Referred to the Subcommittee on Health.
Jun 25, 2004
Referred to the House Committee on Energy and Commerce.
Jun 25, 2004
Introduced in House
 Plain-English summary Congressional Research Service

Dietary Supplement Regulatory Implementation Act of 2004 - Makes appropriations for FY 2005, and authorizes appropriations for FY 2006 through 2009: (1) to carry out the Dietary Supplement Health and Education Act of 1994 (DSHEA), the amendments made by DSHEA, and all applicable regulatory requirements for dietary supplements under the Federal Food, Drug, and Cosmetic Act; and (2) for expanded research and development of consumer information, including information on safety and beneficial effects, of dietary supplements by the Office of Dietary Supplements at the National Institutes of Health.

Directs the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to: (1) fully and appropriately use such funds to regulate dietary supplements; (2) report annually on DSHEA implementation and enforcement; (3) carry out programs to educate health professionals and consumers on the safety and health benefits of the dietary supplements, including the potential for interactions of dietary supplements and drugs (using specified funds authorized by this Act); and (4) establish a system for the requirements for the reporting of serious adverse experiences associated with the use of a dietary supplement received by the manufacturer, packer, or distributor whose name appears on the label of the product.

Expresses the sense of the Congress regarding dietary supplements containing ephedrine alkaloids.

What's happening now July 7, 2004

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2